Is Working Night Shift a Carcinogen? Cancer Risk Explained

Night shift work is classified as a “probable carcinogen” by the International Agency for Research on Cancer (IARC), the World Health Organization’s cancer research arm. That classification, formally designated Group 2A, places night shift work in the same risk category as some well-known chemical exposures. The label does not mean every night worker will develop cancer, but it reflects a body of evidence strong enough that researchers treat the link as real, even if the precise size of the risk varies by cancer type, duration of shift work, and individual biology.

What the IARC Classification Actually Means

IARC first flagged shift work involving circadian disruption as a probable human carcinogen in 2007, based on accumulating evidence from animal experiments and human studies.¹ In June 2019, a new working group revisited the evidence and reaffirmed the Group 2A classification, this time specifying “night shift work” rather than the broader “shift work involving circadian disruption.”² The tightened language matters: IARC concluded it is specifically the nighttime component, not just irregular hours, that drives the concern.

Group 2A sits one notch below Group 1 (“carcinogenic to humans”), where agents like tobacco smoke and asbestos live. It means the evidence in humans is “limited” but backed by “sufficient” evidence in animals and strong mechanistic data. In practice, it is a category reserved for exposures where the biological plausibility is clear and the human epidemiology is pointing in a consistent direction, even if the studies are not yet airtight.

How Night Work Disrupts the Body’s Cancer Defenses

Your body relies on an internal clock, centered in a small brain region called the suprachiasmatic nucleus, to coordinate hormone release, cell repair, immune surveillance, and metabolism with the day-night cycle. Night shift work throws a wrench into nearly all of these processes at once. Researchers have identified several overlapping biological pathways through which that disruption may promote cancer.

Melatonin Suppression

Melatonin, the hormone your brain normally ramps up after dark, does more than make you sleepy. It acts as an antioxidant, helps trigger the self-destruction of damaged cells, and interferes with several signaling pathways that tumors rely on to grow and spread.³ Additional research has documented anticancer, anti-inflammatory, and immune-boosting properties of melatonin.⁴ When you are awake under artificial light at night, melatonin production drops. A systematic review and meta-analysis confirmed that night shift workers show suppressed melatonin levels, with the effect especially pronounced among fixed night shift workers who are consistently exposed to light during their body’s biological night.⁵

The wavelength of light matters. Short-wavelength light, the blue-enriched kind emitted by overhead fluorescent tubes and screens, is the most potent suppressor of melatonin. In controlled experiments, filtering out wavelengths below 530 nanometers with amber-tinted goggles preserved melatonin levels even under bright 800-lux lighting, while unfiltered bright light drastically suppressed production.⁶ That finding has practical implications explored later in this article.

DNA Damage and Impaired Repair

Your cells accumulate DNA damage constantly from normal metabolism, and a suite of repair genes fixes that damage, largely on a circadian schedule. Night shift work appears to knock that schedule off-kilter. In a controlled human study, a simulated day shift schedule showed significant rhythmic expression of DNA repair genes, but a simulated night shift schedule did not, and participants showed increased sensitivity to both internal and external sources of DNA damage after the night shift condition.⁷

A pilot study measuring oxidative DNA damage markers in real-world night workers found that levels of a key damage marker, 8-oxodG, rose significantly during a nightshift period and remained elevated even a month after the workers stopped doing night shifts.⁸ That persistence suggests the body does not simply bounce back the moment the schedule changes.

Runaway Cell Proliferation

The circadian clock is tightly linked to the cell cycle, the process that governs when cells divide. When that link is broken, cells can start multiplying without the usual checkpoints. At a molecular level, circadian disruption has been shown to dysregulate not just cell division but also the processes that kill off defective cells, prevent tumors from spreading, and allow the immune system to detect cancer.⁹ Experimental work has pinpointed genes controlling the G1/S phase transition, a critical cell-division checkpoint, as being abnormally activated when circadian rhythms are chronically disrupted, which pushes cells toward uncontrolled growth.¹⁰

Weakened Immune Surveillance

Natural killer (NK) cells are part of your immune system’s frontline tumor patrol. In rat experiments, chronic shift-lag conditions suppressed the normal circadian rhythm of NK cell activity and reduced their ability to kill tumor cells when stimulated. Rats subjected to chronic circadian disruption showed significantly more lung tumor growth after being injected with cancer cells compared with rats on a stable light-dark cycle.¹¹ Animal evidence is not automatically applicable to people, but the mechanism aligns with what we know about circadian control of the human immune system.

What the Cancer Numbers Look Like in Shift Workers

The strongest epidemiological evidence links night shift work to breast cancer. Other cancers, particularly prostate and colorectal, also show associations, but the data are less consistent.

Breast Cancer

A case-control study of women working night shifts found the risk of breast cancer was roughly 2.6 times higher than in women who did not do night work, and that risk climbed further when women worked more than three consecutive night shifts or accumulated more than ten years on night schedules.¹² Even after adjusting for confounders like BMI, smoking, menstrual history, and pregnancy, shift workers in the same study population had roughly twice the odds of breast cancer compared with non-shift workers.¹³

Large prospective cohort data paint a more nuanced picture. In the two Nurses’ Health Studies, the first cohort showed no clear link between rotating night shift duration and breast cancer risk even at 30-plus years. But in the second cohort, women who had done 20 or more years of rotating night shifts had roughly double the risk, and cumulative night shift exposure of 20-plus years was associated with about a 40 percent increase in breast cancer risk.¹⁴ The discrepancy between the two cohorts has puzzled researchers and may reflect differences in how shift work was measured or changing workplace conditions over decades.

A systematic review and meta-analysis pooling 61 studies estimated that for every five years of night shift work, a woman’s breast cancer risk increased by about three percent.¹⁵ That incremental figure sounds modest, but it compounds over a career. A nurse who racks up 25 years of nights might carry a meaningfully higher cumulative risk than someone who did five years and switched to days.

Prostate Cancer

Night shift work has been associated with an increased prostate cancer risk, with rotating night shifts showing a stronger link than fixed nights. One case-control study found that rotating night shift workers had about a 73 percent higher odds of prostate cancer compared with day workers.¹⁶ Among Norwegian offshore petroleum workers, those who had done roughly 20 or more years of rollover shift work had an 86 percent higher hazard of aggressive prostate cancer.¹⁷

Genetics may interact with shift work exposure here. A prospective study found that a specific variant in the melatonin receptor gene (MTNR1B) modified prostate cancer risk among night shift workers: carriers of certain versions of the gene had a substantially lower risk despite working nights, suggesting that individual biology can amplify or dampen the effect of circadian disruption.¹⁸

Colorectal Cancer

The evidence for colorectal cancer is weaker and more mixed. Two large nurse cohorts found no overall association between rotating night shift work and colorectal cancer, though risk for rectal cancer specifically did increase with longer shift work duration.¹⁹ A Dutch study of over 56,000 nurses similarly found no overall increased colorectal cancer risk from ever working night shifts, but a higher cumulative number of night shifts was associated with a slight uptick.²⁰ Fifteen or more years of night shift work showed a marginal trend toward increased colorectal cancer, and the association was stronger for tumors expressing specific insulin receptor substrate proteins.²¹ The overall picture: if night work raises colorectal cancer risk, the effect is much smaller than for breast or prostate cancer and may depend on tumor biology.

Confounders That Muddy the Picture

One persistent criticism of night shift studies is that shift workers differ from day workers in ways that independently affect cancer risk. They tend to get less sunlight, which lowers vitamin D. A meta-analysis confirmed that shift workers have significantly lower circulating vitamin D than their daytime counterparts, driven by reduced sunlight exposure, poorer diet, and higher body mass index (which traps vitamin D in fat tissue).²² Vitamin D deficiency has been separately linked to elevated cancer risk, making it hard to disentangle how much of the shift-work effect is circadian disruption and how much is simply low vitamin D.

Night workers also tend to eat at biologically inappropriate times. Emerging research suggests that nocturnal eating itself, independent of what is eaten, disturbs gut microbiota and circadian metabolism in ways that may promote digestive cancers.²³ Shift workers also show higher insulin resistance and markers of oxidative stress and inflammation compared with workers on ergonomic schedules, even after accounting for other factors.²⁴ Higher insulin resistance and chronic inflammation are known risk factors for several cancers, adding another thread to the mechanistic web.²⁵

The best epidemiological studies try to adjust for these lifestyle confounders, and most still find an elevated cancer risk after adjustment. But no observational study can fully separate circadian disruption from the cluster of unhealthy behaviors and exposures that tend to travel with night work. That residual uncertainty is a major reason the IARC classification stays at Group 2A (“probable”) rather than graduating to Group 1 (“definite”).

Does Your Chronotype Matter?

You might assume that natural night owls tolerate night shifts better and face less cancer risk. A recent meta-analysis tested that assumption and found it does not hold up neatly. Both morning-type and evening-type night shift workers showed elevated breast cancer risk compared with day workers. For prostate cancer, however, the picture was more troubling for evening types: night shift workers with an evening chronotype were 84 percent more likely to develop prostate cancer than daytime workers, and each additional year of night shifts increased prostate cancer risk by about two percent in this group.²⁶

The authors were blunt: chronotype-matched scheduling, putting night owls on night shifts, does not effectively mitigate the health risks. Working against the light-dark cycle apparently disrupts circadian biology regardless of whether you feel more alert at 2 a.m. than the average person.

Animal Evidence and Light-at-Night Experiments

Animal studies allow researchers to isolate variables that are hopelessly tangled in human epidemiology. When human breast cancer tissue was grown in rats kept on a normal light-dark cycle, tumors grew steadily. But when the same tumors were exposed to dim light at night, which suppressed the rats’ melatonin, the tumor growth rate roughly doubled. The light-at-night condition also triggered higher blood sugar and insulin in the host animals and ramped up the metabolic machinery tumors use to fuel their growth.²⁷

Even the intensity of ambient light in a laboratory cage affects tumor outcomes. Mice housed under abnormally low or abnormally high light carried significantly heavier tumors than those under moderate lighting, underscoring how sensitive cancer biology is to the light environment.²⁸ These animal results are not proof that the same magnitudes apply to humans, but they provide a controlled demonstration of the mechanism that epidemiology can only infer.

Reducing Risk If You Work Nights

Quitting night shifts is the most direct way to reduce exposure, but it is not realistic for millions of healthcare workers, factory operators, emergency responders, and others whose jobs demand it. Several evidence-based strategies can at least lower the biological toll.

Blue-light filtering is one of the most studied interventions. Amber-tinted glasses that block wavelengths below about 530 nanometers have been shown to preserve melatonin production even under bright workplace lighting.⁶ A newer approach, filtering short-wavelength light from just one eye, also maintained high melatonin levels while preserving alertness and visual performance, suggesting a less intrusive option for workers who need full color vision.²⁹ Pairing blue-light blocking during daytime sleep with strategically timed blue-green light exposure during the night shift has shown improvements in alertness, performance, and melatonin rhythm shifting in a pilot study.³⁰

Melatonin supplementation has also been explored. A randomized placebo-controlled trial among night shift workers found that melatonin supplementation was associated with a borderline significant improvement in the body’s ability to repair oxidative DNA damage during daytime sleep, as measured by a roughly 1.8-fold increase in urinary excretion of the damage marker 8-OH-dG.³¹ The result hovered at the edge of statistical significance, so it is promising rather than conclusive, and questions about optimal timing and dose remain open.

Schedule design itself matters. Based on the available evidence on injuries and breast cancer risk, researchers have recommended that night shift schedules include no more than three consecutive night shifts, at least 11 hours between shifts, and shift durations of nine hours or less.³² Forward rotation, where shifts progress from morning to afternoon to night rather than the reverse, has also been associated with lower breast cancer risk in studies that tracked shift patterns.¹²

Biological Aging and Shift Work

Beyond cancer specifically, there is growing interest in whether night shift work accelerates biological aging, which would compound disease risk over time. Researchers have used DNA methylation patterns as a molecular clock to estimate biological versus chronological age. A study examining shift workers found that shift work was associated with altered DNA methylation and with accelerated epigenetic aging, consistent with long-term negative health consequences.³³ In plainer terms, the molecular wear and tear on a night worker’s cells may outpace what their birth certificate would predict. Accelerated biological aging is itself a risk factor for cancer, cardiovascular disease, and neurodegeneration, so this finding hints at a broader mechanism through which night work extracts a toll beyond any single disease.

Legal Recognition Across Countries

Whether night-shift-related cancer qualifies for workers’ compensation varies dramatically by country. South Korea’s Epidemiologic Investigation Evaluation Committee has recognized prostate cancer cases in long-term night shift workers as occupational disease, and the country defines night work as hours between roughly 9 p.m. and 6 a.m., a definition similar to France’s.³⁴ Denmark made headlines in 2009 by compensating breast cancer in women with long histories of night work, though the policy remains an exception globally. Most countries have not yet translated the IARC classification into occupational health policy, leaving workers without formal recognition of the risk they carry.

The gap between what the science says and what workplace regulations reflect is wide. Occupational health guidelines from bodies like the American Academy of Sleep Medicine and the Sleep Research Society call for evidence-based approaches to shift duration and fatigue management, emphasizing fatigue countermeasures and workplace-specific strategies, but they stop short of recommending specific cancer-prevention protocols.³⁵ For now, individual workers and their employers are largely left to act on the evidence themselves.